Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCalidi Biotherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Calidi Biotherapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
    Sep 25, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
    Sep 17, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
    Sep 8, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
    Aug 13, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
    Jul 27, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
    Jul 21, 2026Calidi Biotherapeutics Press Releases
  • Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
    Jul 20, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
    Jul 8, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
    Jun 24, 2026Calidi Biotherapeutics Press Releases
  • Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
    Jun 23, 2026Calidi Biotherapeutics Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.01Close · Jul 16, 2026